Technical analysis of TuHURA Biosciences, Inc. (HURA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
Price Performance
| 1 month | -6.02% |
| 3 months | -21.01% |
| Year-to-date | +168.27% |
| 1 year | -16.46% |
| 3 years | -44.84% |
| 5 years | -97.10% |
52-Week Range
| 52-week High | $3.43 |
| 52-week Low | $0.41 |
| Avg Volume (90d) | 420K |
Technical Indicators
| SMA 50 | $2.17 |
| SMA 200 | $1.82 |
| Beta | -0.32 |
| 30-day Volatility (annualised) | 65.6% |
| Price vs SMA 50 | -6.6% |
| Price vs SMA 200 | +11.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $2.55 | |
| 2025-11 | $2.00 | -21.6% |
| 2025-12 | $0.76 | -62.2% |
| 2026-01 | $0.54 | -29.3% |
| 2026-02 | $1.67 | +212.1% |
| 2026-03 | $1.79 | +7.2% |
| 2026-04 | $2.24 | +25.1% |
| 2026-05 | $2.26 | +0.9% |
| 2026-06 | $2.34 | +3.5% |
| 2026-07 | $2.17 | -7.3% |
| 2026-08 | $2.13 | -1.8% |
| 2026-09 | $2.03 | -4.7% |
Price
| Price | $2.03 |
| Market Cap | $129M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 7.09 |
| EV / EBITDA | -4.38 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.02 |
| Current Ratio | 0.18 |